Hopp til innhold

Bergen Teknologioverføring (BTO) har skiftet navn til VIS.

Du har nå kommet til VIS sin nye nettside. Visinnovasjon.no erstatter nettsidene bergento.no og nyskapingsparken.no.

Det formelle navneskiftet ble foretatt 14. februar 2019.

Visinnovasjon.no > Aktuelt > BTO brings two projects to BioVaria
VIS logo Logo for VIS

BTO brings two projects to BioVaria

Our business developers will present the two projects "3D-printed polymer scaffolds in bone regeneration" and "Genetic expression of Neosaxitoxin for pain modulation" at the yearly conference BioVaria, that will find place in Munich, Germany 22. - 23. May.
05.04.2017

BioVaria is Europe’s leading marketplace for life-science inventions, and the conference attracts numerous decision makers from industry and venture capital, looking for cutting-edge academic projects.

BioVaria brings together European research institutions across national borders in order to improve the transfer of their research results into application. Europe’s most established technology transfer organizations join to present their most promising projects from academia to decision makers from international industry.

It is considered a must-join event for innovation scouts and business developers from the international biopharmaceutical industry looking for in-licensing and collaboration opportunities, and for venture capitalists looking for high-potential start-ups or IP assets to complement their investment portfolios.

Projects at the conference

BTO is one of the technology transfer partners of the event, and we will present two projects on the conference.

The project «3D-printed polymer scaffolds in bone regeneration» are replacing larger bone fragments with personalized, mechanically resistant scaffold instantly interacting with surrounding tissues. Read the project presentation at BioVaria’s webpage, and find more information about the 3D-project at our webpage.

The second project that will be presented at BioVaria is «Genetic expression of Neosaxitoxin for pain modulation»,  that has developed a first in class technology to express the Neosaxitoxin biosynthetic pathway. You can read the project presentation at BioVaria’s webpage.

ekspander_ikon_20x20_svartekspander_ikon_20x20fb_28x28footer_vislogo_167x85hopptil-pilinsta_28x28kvitpil_ikon_19x13linkedin_28x28logo_toppmeny_vis_logo_59x50nfr_merke_250x103nonameraudpil_ikon_19x13siva-partner_hoover_291x48siva-partner_liggende_291x48twitter_28x28